Several variants affecting the SARS-CoV-2 binding region of ACE2 has been proposed (e.g. rs73635825, rs4646116 and rs766996587) as candidate variants to be studied in relation to COVID-19 [19] [preprint: not peer-reviewed], these variants still need to be assessed in large samples. This evidence concerns the gene ACE2 and COVID-19.